Davenport & Co’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Davenport & Co’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-7,917	Closed	-$427K	–	596
2015 Q4	$427K	Buy	7,917 +930	+13%	+$48.9K	0.01%	389
2015 Q3	$345K	Sell	6,987 -1,590	-19%	-$91.1K	0.01%	421
2015 Q2	$500K	Buy	8,577 +180	+2%	+$10.5K	0.01%	388
2015 Q1	$483K	Buy	8,397 +2,580	+44%	+$141K	0.01%	400
2014 Q4	$294K	Hold	5,817	–	–	﹤0.01%	469
2014 Q3	$272K	Sell	5,817 -150	-3%	-$6.77K	﹤0.01%	474
2014 Q2	$269K	Buy	5,967 +150	+3%	+$6.45K	﹤0.01%	490
2014 Q1	$246K	Buy	+5,817	New	+$244K	﹤0.01%	499

Other funds holding IHE

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AWA

ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

SFI

SPC Financial Inc Rockville, Maryland $1.28B AUM 12.6% 1-Year Est. Return

Spinnaker Trust Portland, Maine $2.06B AUM 24.94% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

EAMA

EFG Asset Management (Americas) Miami, Florida $579M AUM 24.22% 1-Year Est. Return

Davenport & Co's IHE Position: Q1 2016 in Review

Davenport & Co sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2016, closing a stake of 7,917 shares — an estimated $427K sold.

Davenport & Co first reported a position in IHE in Q1 2014 and held it in 8 quarters. The position peaked at $500K in Q2 2015. 91 funds tracked by Wall St. Rank hold IHE as of Q1 2016.

Davenport & Co reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2016 after selling out during the quarter.
Davenport & Co sold 7,917 iShares US Pharmaceuticals ETF shares in Q1 2016, an estimated $427K.
Davenport & Co first reported a position in iShares US Pharmaceuticals ETF in Q1 2014 and held it in 8 quarters.
Davenport & Co's iShares US Pharmaceuticals ETF position peaked at $500K in Q2 2015.
91 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2016.

Based on Davenport & Co's 13F filing for Q1 2016, filed 25 Apr 2016.